WallStSmart
NEOG

Neogen Corporation

NASDAQ: NEOG · HEALTHCARE · MEDICAL DEVICES

$11.78
+0.08% today

Updated 2026-09-11

Market cap
$2.60B
P/E ratio
P/S ratio
2.99x
EPS (TTM)
$-0.04
Dividend yield
52W range
$5 – $13
Volume
2.0M

Neogen Corporation (NEOG) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20072008200920102011201220132014201520162017201820192020202120222023202420252026
Revenue$86.14M$102.42M$118.72M$140.51M$172.68M$184.05M$207.53M$247.41M$283.07M$321.27M$361.59M$402.25M$414.19M$418.17M$468.46M$527.16M$822.45M$924.22M$894.66M$870.40M
Revenue growth (YoY)+18.9%+15.9%+18.4%+22.9%+6.6%+12.8%+19.2%+14.4%+13.5%+12.5%+11.2%+3.0%+1.0%+12.0%+12.5%+56.0%+12.4%-3.2%-2.7%
Cost of revenue$41.58M$49.19M$59.29M$67.53M$84.89M$91.62M$98.03M$124.81M$143.39M$168.21M$189.63M$212.00M$222.27M$221.89M$253.40M$284.15M$416.49M$461.59M$473.29M$461.90M
Gross profit$44.56M$53.23M$59.43M$72.97M$87.79M$92.42M$109.49M$122.60M$139.69M$153.06M$171.97M$190.25M$191.92M$196.28M$215.06M$243.01M$405.95M$462.63M$421.38M$408.50M
Gross margin51.7%52.0%50.1%51.9%50.8%50.2%52.8%49.6%49.3%47.6%47.6%47.3%46.3%46.9%45.9%46.1%49.4%50.1%47.1%46.9%
R&D$3.29M$3.64M$4.55M$6.26M$6.83M$6.64M$7.78M$8.33M$9.58M$9.89M$10.38M$10.86M$12.80M$14.75M$16.25M$17.05M$26.04M$22.48M$21.09M$18.40M
SG&A$27.76M$31.57M$11.48M$13.49M$15.11M$17.02M$20.22M$24.45M$25.23M$29.19M$34.21M$38.29M$40.79M$44.33M$51.20M$82.74M$201.18M$199.89M$218.17M$245.10M
Operating income$13.50M$18.02M$20.49M$26.88M$35.84M$33.74M$40.71M$43.39M$53.12M$56.39M$64.94M$70.19M$68.09M$67.52M$74.17M$58.62M$37.52M$77.43M$9.42M$-21.60M
Operating margin15.7%17.6%17.3%19.1%20.8%18.3%19.6%17.5%18.8%17.6%18.0%17.5%16.4%16.1%15.8%11.1%4.6%8.4%1.1%-2.5%
EBITDA$16.73M$22.01M$25.51M$31.76M$40.57M$39.91M$48.12M$52.57M$63.77M$68.93M$79.64M$87.25M$90.58M$90.70M$96.31M$83.90M$125.89M$182.60M$-937.75M$170.50M
EBITDA margin19.4%21.5%21.5%22.6%23.5%21.7%23.2%21.2%22.5%21.5%22.0%21.7%21.9%21.7%20.6%15.9%15.3%19.8%-104.8%19.6%
EBIT$13.89M$18.50M$21.62M$27.32M$35.24M$33.74M$40.71M$43.39M$53.12M$56.39M$64.94M$70.19M$72.96M$72.31M$75.27M$60.21M$37.52M$61.37M$-1.06B$48.60M
Interest expense$15.00M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$22.49M$23.18M$78000.00$72000.00$55.96M$73.39M$71.62M$57.60M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$9.13M$12.10M$13.87M$17.52M$22.84M$22.51M$27.19M$28.16M$33.53M$36.56M$43.79M$63.15M$60.18M$59.48M$60.88M$48.31M$-22.87M$-9.42M$-1.09B$-7.90M
Net income growth (YoY)+32.6%+14.7%+26.3%+30.4%-1.4%+20.8%+3.6%+19.1%+9.1%+19.8%+44.2%-4.7%-1.2%+2.4%-20.7%-147.3%+58.8%-11491.6%+99.3%
Profit margin10.6%11.8%11.7%12.5%13.2%12.2%13.1%11.4%11.8%11.4%12.1%15.7%14.5%14.2%13.0%9.2%-2.8%-1.0%-122.1%-0.9%

Frequently asked questions

What is Neogen Corporation's revenue?

Neogen Corporation's trailing twelve-month revenue is $870.40M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is NEOG?

In its most recent fiscal year, NEOG ran a gross margin of 46.93%, an operating margin of -2.48%, and a net margin of -0.91%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NEOG generate?

NEOG produced $31.90M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NEOG's balance sheet healthy?

NEOG holds $185.50M in cash and equivalents against $793.70M in long-term debt, on $2.09B of shareholder equity. That debt is best read against the cash flow the business throws off each year.